Madrigal Pharmaceuticals (MDGL) Leases (2019 - 2025)
Historic Leases for Madrigal Pharmaceuticals (MDGL) over the last 10 years, with Q3 2025 value amounting to $5.4 million.
- Madrigal Pharmaceuticals' Leases rose 11445.06% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 11445.06%. This contributed to the annual value of $2.4 million for FY2024, which is 4016.35% up from last year.
- Per Madrigal Pharmaceuticals' latest filing, its Leases stood at $5.4 million for Q3 2025, which was up 11445.06% from $5.9 million recorded in Q2 2025.
- Madrigal Pharmaceuticals' Leases' 5-year high stood at $5.9 million during Q2 2025, with a 5-year trough of $411000.0 in Q2 2023.
- In the last 5 years, Madrigal Pharmaceuticals' Leases had a median value of $1.1 million in 2022 and averaged $1.7 million.
- Its Leases has fluctuated over the past 5 years, first crashed by 6111.64% in 2023, then surged by 30260.99% in 2025.
- Over the past 5 years, Madrigal Pharmaceuticals' Leases (Quarter) stood at $797000.0 in 2021, then fell by 24.47% to $602000.0 in 2022, then surged by 184.55% to $1.7 million in 2023, then soared by 40.16% to $2.4 million in 2024, then soared by 124.36% to $5.4 million in 2025.
- Its Leases stands at $5.4 million for Q3 2025, versus $5.9 million for Q2 2025 and $2.1 million for Q1 2025.